Outcomes and endpoints of relevance in gynecologic cancer clinical trials
Outcomes and endpoints of relevance in gynecologic cancer clinical trials
About this item
Full title
Author / Creator
Publisher
United States: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Drug development is paramount to improve outcomes in patients with gynecologic cancers. A randomized clinical trial should measure whether a clinically relevant improvement is detected with the new intervention compared with the standard of care, using reproductible and appropriate endpoints. Clinically meaningful improvements in overall survival a...
Alternative Titles
Full title
Outcomes and endpoints of relevance in gynecologic cancer clinical trials
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2784384706
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2784384706
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2022-003727
